Ocular Implants Market Size, Share, Forecast, & Trends Analysis by Type (Scleral, Stock, Orbital, Intraocular, Retinal, Corneal) Material (Silicon, Hydroxyapatite) Application (Prosthesis, Ocuplasty, Glaucoma Surgery) End User

Description

List of Tables

Ocular Implants Market Size, Share, Forecast, & Trends Analysis by Type (Scleral, Stock, Orbital, Intraocular, Retinal, Corneal), Material (Silicon, Hydroxyapatite), Application (Prosthesis, Oculoplasty, Glaucoma Surgery), End User - Global Forecast to 2031

The ocular implants market is projected to reach $23.43 billion by 2031 at a CAGR of 6.1% from 2024 to 2031.

After extensive secondary and primary research and an in-depth analysis of the market scenario, the report provides an analysis of key industry drivers, restraints, opportunities, and challenges. The growth of the ocular implants market is driven by the increasing geriatric population coupled with the high prevalence of eye diseases, the rising adoption of minimally invasive surgeries, increasing healthcare expenditure, technological advancements in ocular implants, increasing accident cases, and the rising need for ocular implants. However, the risk of post-surgery infection and inflammation, the lack of skilled ophthalmic surgeons, and strict regulations and approval processes restrain the growth of this market.

Additionally, the lack of awareness in rural areas, technological complexities, high implant costs, and increasing product recalls are major challenges in the ocular implants market. Furthermore, biomaterial-based ocular implants, AI-driven 3D-printed prosthetic eyes, and drug-eluting implants are prominent trends in the ocular implants market.

The report offers a competitive landscape based on an extensive assessment of the leading players' product portfolios, geographic presence, and key strategies adopted over the last four years (2020-2024). The key players operating in the ocular implants market are Alcon Inc. (Switzerland), Bausch + Lomb Corporation (Canada), Carl Zeiss AG (Germany), Johnson & Johnson Vision Care, Inc. (U.S.), STAAR SURGICAL COMPANY (U.S.), Morcher GmbH (Germany), HOYA CORPORATION (Japan), GLAUKOS CORPORATION (U.S.), AbbVie Inc. (U.S.), and Vivani Medical Inc. (U.S.).

Based on type, in 2024, the functional implants segment is expected to account for the major share of 81.7% of the ocular implants market. The functional implants segment is further categorized into intraocular lenses, glaucoma implants, retinal implants, and corneal implants. The large share of this segment is attributed to the increasing prevalence of glaucoma, the growing demand for functional implants owing to rising eye injuries, and technological advances in functional implants. For instance, according to the Centers for Disease Control and Prevention report of February 2024, more than 3 million people in America have glaucoma, and it is estimated that by 2050, the number will rise to 6.3 million.

Based on material, the ocular implants market is segmented into inert materials and biointegrated materials. The inert materials segment is further segmented into glass, silicone, and methyl methacrylate. In 2024, the inert materials segment is expected to account for the larger share of the ocular implants market. The large market share of this segment can be attributed to the cost-effectiveness of inert materials and the high preference for glass- and silicone-based ocular implants due to their high compatibility and excellent visual appearance.

Among all the applications studied in this report, in 2024, the glaucoma surgery segment is expected to account for the largest share of the ocular implants market. The large share of this segment is attributed to the increasing prevalence of glaucoma and the rising demand for functional implants in severe glaucoma cases. Additionally, individuals with diabetes, farsightedness, or eye injury are more likely to experience glaucoma. For instance, according to the World Health Organization report of 2024, approximately 422 million people have diabetes worldwide. Thus, the high incidence of diabetes supports the segment's large share.

Based on end user, the ocular implants market is segmented into hospitals, ophthalmic clinics, Ambulatory Surgery Centers (ASCs), and other end users. In 2024, the hospitals segment is expected to account for the largest share of the ocular implants market. The large market share of this segment can be attributed to the easy accessibility of hospitals, patients' high preference for hospitals as the first choice for diagnosis and therapies, and the availability of advanced instruments in hospitals.

An in-depth analysis of the geographical scenario in the ocular implants market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of 41.8% of the ocular implants market. North America's large market share is attributed to the high healthcare expenditure, increasing prevalence of eye disorders, presence of key players, access to advanced treatment due to well-developed healthcare infrastructure, rising number of patients opting for ophthalmic surgeries, and availability of advanced ocular implant products in the region. In North America, the U.S. is expected to account for the major share in 2024, mainly due to high healthcare expenditure, growth in the aging population, favorable government policies, and the presence of key players in the region.

Scope of the Report:

Ocular Implants Market Assessment-by Type

Non-functional Implants
- Ocular Implants
Scleral Shells
Stock Shells
Custom-made Prosthesis
- Orbital Implants
Functional Implants
- Intraocular Lenses
- Glaucoma Implants
- Retinal Implants
- Corneal Implants

Ocular Implants Market Assessment-by Material

Inert Materials
- Glass
- Silicone
- Methyl Methacrylate
Biointegrated Materials
- Hydroxyapatite
- Porous Polyethylene
- Aluminum Oxide

Ocular Implants Market Assessment-by Application

Ocular Prosthesis
Glaucoma Surgery
Oculoplasty
Drug Delivery
Other Applications

Note: Other applications include vision correction, cosmetic surgery, and age-related macular degeneration.

Ocular Implants Market Assessment-by End User

Hospitals
Ophthalmic Clinics
Ambulatory Surgery Centers (ASCs)
Other End Users

Note: Other end users include academic & research institutes and pharmaceutical & biotechnology companies.

Ocular Implants Market Assessment-by Geography

North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K
- Italy
- Spain
- Netherlands
- Switzerland
- Sweden
- Belgium
- Rest of Europe (RoE)
Asia-Pacific (APAC)
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific (RoAPAC)
Latin America
- Brazil
- Mexico
- Rest of Latin America (RoLATAM)
Middle East & Africa

Product Code: MRHC - 1041245

1. Introduction

1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders

2. Research Methodology

2.1. Research Approach
2.2. Data Collection & Validation Process
- 2.2.1. Secondary Research
- 2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Sizing & Forecasting
- 2.3.1. Market Size Estimation Approach
- 2.3.2. Growth Forecast Approach
- 2.3.3. Market Share Analysis
2.4. Assumptions for the Study

3. Executive Summary

4. Factors Affecting Market Growth

4.1. Overview
4.2. Drivers
- 4.2.1. Rising Geriatric Population Coupled with High Prevalence of Eye Diseases
- 4.2.2. Rise in Adoption of Minimally Invasive Surgeries
- 4.2.3. Increasing Healthcare Expenditure
- 4.2.4. Technological Advancements in Ocular Implants
- 4.2.5. Increasing Accident Cases Raising the Need for Ocular Implants
4.3. Restraints
- 4.3.1. Risk of Post-surgery Infections and Inflammations
- 4.3.2. Lack of Skilled Ophthalmic Surgeons
- 4.3.3. Strict Regulations and Approval Process
4.4. Opportunities
- 4.4.1. Ocular Nanotechnology-based Drug Delivery
- 4.4.2. Ocular Tissue Engineering
4.5. Challenges
- 4.5.1. Lack of Awareness in Rural Areas
- 4.5.2. Technological Complexities
- 4.5.3. High Cost of Implants
- 4.5.4. Increasing Number of Product Recalls
4.6. Trends
- 4.6.1. Biomaterial-based Ocular Implants
- 4.6.2. AI-driven 3D Printed Prosthetic Eyes
- 4.6.3. Drug-eluting Implants
4.7. Factor Analysis
4.8. Regulatory Analysis
4.9. Pricing Analysis
4.10. Case Studies
4.11. Porter's Five Forces Analysis

5. Ocular Implants Market Assessment, by Type

5.1. Overview
5.2. Non Functional Implants
- 5.2.1. Ocular Implant
  - 5.2.1.1. Scleral Shells
  - 5.2.1.2. Stock Shells
  - 5.2.1.3. Custom Made Prosthesis
- 5.2.2. Orbital Implants
5.3. Functional Implants
- 5.3.1. Intraocular Lens
- 5.3.2. Glaucoma Implants
- 5.3.3. Retinal Implants
- 5.3.4. Corneal Implants

6. Ocular Implants Market Assessment, by Material

6.1. Overview
6.2. Inert materials
- 6.2.1. Glass
- 6.2.2. Silicone
- 6.2.3. Methylmethacrylate
6.3. Biointegrated Materials
- 6.3.1. Hydroxyapatite
- 6.3.2. Porous Polyethylene
- 6.3.3. Aluminum Oxide

7. Ocular Implants Market Assessment, by Application

7.1. Overview
7.2. Ocular Prosthesis
7.3. Glaucoma Surgery
7.4. Oculoplasty
7.5. Drug Delivery
7.6. Other Applications

8. Ocular Implants Market Assessment, by End User

8.1. Overview
8.2. Hospitals
8.3. Ophthalmic Clinics
8.4. Ambulatory Surgery Centers (ASCs)
8.5. Other End Users

9. Ocular Implants Market Assessment, by Geography

9.1. Overview
9.2. North America
- 9.2.1. U.S.
- 9.2.2. Canada
9.3. Europe
- 9.3.1. Germany
- 9.3.2. France
- 9.3.3. U.K.
- 9.3.4. Italy
- 9.3.5. Spain
- 9.3.6. Netherlands
- 9.3.7. Switzerland
- 9.3.8. Sweden
- 9.3.9. Belgium
- 9.3.10. Rest of Europe (RoE)
9.4. Asia-Pacific
- 9.4.1. China
- 9.4.2. Japan
- 9.4.3. India
- 9.4.4. Australia
- 9.4.5. South Korea
- 9.4.6. Rest of Asia-Pacific (RoAPAC)
9.5. Latin America
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America (RoLATAM)
9.6. Middle East & Africa

10. Competition Analysis

10.1. Overview
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Competitive Dashboard
- 10.4.1. Industry Leaders
- 10.4.2. Market Differentiators
- 10.4.3. Vanguards
- 10.4.4. Emerging Companies
10.5. Market Share Analysis of Key Players (2023)

11. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)

11.1. Alcon Inc.
11.2. Bausch + Lomb Corporation
11.3. Carl Zeiss AG
11.4. Johnson & Johnson Vision Care, Inc.
11.5. STAAR Surgical Company
11.6. Morcher GmbH
11.7. Hoya Corporation
11.8. Glaukos Corporation
11.9. ABBVIE INC.
11.10. Vivani Medical Inc.

(Note: SWOT analyses of the top 5 companies will be provided.

12. Appendix

12.1. Available Customization
12.2. Related Reports